About palivizumab
Respiratory syncytial virus monoclonal antibody
Used for
- Prevention of serious respiratory syncytial virus (RSV) disease in high-risk infants and young children.
Usual adult dose
Not used in adults.
Usual dose in children
15 mg/kg injected into a muscle monthly during RSV season; timing and number of doses depend on local guidance.
Common side effects
- Fever
- Rash
- Injection-site reactions
- Rare severe allergic reactions
Important warnings
- Not a treatment for active RSV infection.
- Use caution with bleeding disorders or low platelet counts because it is injected into muscle.
- Severe allergic reactions can occur, including after a previous dose.
Pregnancy
Not applicable; this medicine is intended for infants and young children.
Breastfeeding
Not applicable; this medicine is intended for infants and young children.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.